Mednet Logo
HomeQuestion

How do you choose which LHRH agonist or antagonist to prescribe for ADT in patients with prostate cancer?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · University of Michigan Medical School

The choice of LHRH agonist or antagonist depends on patient factors. Most patients receive some form of leuprolide or goserelin since these allow longer intervals between injections (as compared to degarelix). Goserelin is used more for those on anticoagulation or with bleeding disorders since it is...

Register or Sign In to see full answer

How do you choose which LHRH agonist or antagonist to prescribe for ADT in patients with prostate cancer? | Mednet